| Overview |
| bs-22575R-APC-Cy7 |
| IKK gamma Polyclonal Antibody, APC-Cy7 Conjugated |
| WB |
| Human |
| Mouse, Rat, Cow, Sheep, Pig |
| Specifications |
| APC-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IKK gamma |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 8517 |
| Q9Y6K9 |
| Cytoplasm, Nucleus |
| IkB kinase associated protein 1; IkB kinase subunit gamma; Inhibitor of nuclear factor kappa B kinase subunit gamma; AMCBX1; FIP 3; FIP3; Fip3p; I kappa B kinase gamma; IkB kinase associated protein 1; IkB kinase gamma subunit; IkB kinase subunit gamma; IKBKG; IKKAP 1; IKKAP1; IKKG; Incontinentia pigmenti; Inhibitor of kappa light polypeptide gene enhancer in B cells kinase gamma; Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase gamma; Inhibitor of nuclear factor kappa B kinase gamma subunit; Inhibitor of nuclear factor kappa B kinase subunit gamma; IP 1; IP 2; IP; IP1; IP2; IPD2; NEMO; NF kappa B essential modifier; NF kappa B essential modulator; NF kappaB essential modifier; NF kappaB essential modulator; NFkappaB essential modulator. |
| Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Also considered to be a mediator for TAX activation of NF-kappa-B. Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity (By similarity). Essential for viral activation of IRF3. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz